Conditions: Rheumatoid Arthritis
Keywords: Arthritis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 158
Healthy volunteers: no

Brief summary:
To assess the efficacy of LY2127399 versus placebo using American College of Rheumatology (ACR)50 response scale at 24 weeks

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None arm 5: None arm 6: None arm 7: None

Interventions: intervention 1: LY2127399 intervention 2: Placebo
Intervention descriptions: intervention 1: Administered SC every 4 weeks over a 24-week period (Weeks 0, 4, 8, 12, 16, and 20). intervention 2: Administered subcutaneously (SC) every 4 weeks over a 24-week period (Weeks 0, 4, 8, 12, 16, and 20).

Protocol document: